STEAP3 and colorectal carcinoma: In CRC, hypoxia-induced antisense lncRNA STEAP3-AS1 competed with YTHDF2 to STEAP3 mRNA binding site, protecting STEAP3 mRNA from m6A-mediated degradation and leading to high STEAP3 protein expression.